No topoisomerase I alteration in a neuroblastoma model with in vivo acquired resistance to irinotecan

Podobne zapisy

• Therapeutic activity of CPT-11, a DNA-topoisomerase I inhibitor, against peripheral primitive neuroectodermal tumour and neuroblastoma xenografts.
  od: Vassal, G., i wsp.
  Wydane: (1996)
• Potentiation of radiation therapy by the oncolytic adenovirus dl1520 (ONYX-015) in human malignant glioma xenografts
  od: Geoerger, B, i wsp.
  Wydane: (2003)
• Busulphan is active against neuroblastoma and medulloblastoma xenografts in athymic mice at clinically achievable plasma drug concentrations
  od: Boland, I, i wsp.
  Wydane: (1999)
• In Vivo Elimination of Acentric Double Minutes Containing Amplified MYCN from Neuroblastoma Tumor Cells Through the Formation of Micronuclei
  od: Valent, Alexander, i wsp.
  Wydane: (2001)
• Activity of irinotecan and temozolomide in the presence of O(6)-methylguanine-DNA methyltransferase inhibition in neuroblastoma pre-clinical models
  od: Cai, W, i wsp.
  Wydane: (2010)